Cheng‐chang Chang - Gynecology

Author Information

Cheng-Chang Chang is affiliated with the Department of Obstetrics and Gynecology at Tri-Service General Hospital, National Defense Medical Center, located in Taipei, Taiwan, ROC. His research primarily focuses on gynecological oncology, including ovarian cancer and cervical cancer, as well as the impact of COVID-19 on pregnancy.

Research Contributions

Cheng-Chang Chang has made significant contributions to the field of gynecology through his research on ovarian and cervical cancers, as well as the effects of COVID-19 on pregnant women. Some of his notable works include developing a weakly supervised deep learning method for ovarian cancer treatment and identifying effective biomarkers, exploring the histopathological aspects of ovarian cancer treatment, and investigating the impact of COVID-19 and vaccination during pregnancy. His research also delves into artificial intelligence applications in cervical cancer screening and treatment planning. Cheng-Chang Chang's work has been published in several high-impact journals, reflecting his substantial influence in the field.

Aliases

Cheng-Chang Chang is also known by the aliases Cheng Chang Chang and Cheng-chang Chang.

Publication and Citation Metrics

Metric	Value
Citation Count	2103
h-Index	25
Paper Count	73

Publications:

A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker

DOI: 10.3390/cancers14071651

Year: 2022

Histopathological whole slide image dataset for classification of treatment effectiveness to ovarian cancer

DOI: 10.1038/s41597-022-01127-6

Year: 2022

The impact of COVID-19 in pregnancy: Part II. Vaccination to pregnant women.

DOI: 10.1097/JCMA.0000000000000612

Year: 2021

Artificial intelligence-assisted fast screening cervical high grade squamous intraepithelial lesion and squamous cell carcinoma diagnosis and treatment planning

DOI: 10.1038/s41598-021-95545-y

Year: 2021

AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients

DOI: 10.3390/jcm10194529

Year: 2021

A symptomatic near-term pregnant woman recovered from SARS-CoV-2 infection

DOI: 10.1016/j.tjog.2021.07.046

Year: 2021

The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-19.

DOI: 10.1097/JCMA.0000000000000595

Year: 2021

Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics

DOI: 10.3390/ijms22084105

Year: 2021

Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study

DOI: 10.1016/s0090-8258(21)01277-4

Year: 2021

Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis

DOI: 10.3390/biomedicines9080866

Year: 2021

What Are the Guidelines for Storing Biological Samples?

When Should You Take a Pregnancy Test?

What is Septic Abortion?

What are the Indications for Cefotaxime in Gynecology?

What are the Key Disciplines Involved?

What Techniques Can Patients Use to Manage Anxiety?

What are the Screening Recommendations?

What are Common Codes Used in Gynecology?

How Does a Co-Oximeter Work?

What is the role of the anesthesiologist in managing these risks?

Partnered Content Networks

Relevant Topics